Glenn Sblendorio - Net Worth and Insider Trading
Glenn Sblendorio Net Worth
The estimated net worth of Glenn Sblendorio is at least $18 Million dollars as of 2024-05-11. Glenn Sblendorio is the CEO of IVERIC bio Inc and owns about 244,138 shares of IVERIC bio Inc (ISEE) stock worth over $10 Million. Glenn Sblendorio is the President & CFO of The Medicines Co and owns about 99,805 shares of The Medicines Co (MDCO) stock worth over $8 Million. Glenn Sblendorio is also the Director of Amicus Therapeutics Inc and owns about 11,933 shares of Amicus Therapeutics Inc (FOLD) stock worth over $110,142. Details can be seen in Glenn Sblendorio's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Glenn Sblendorio has not made any transactions after 2022-12-19 and currently still holds the listed stock(s).
Transaction Summary of Glenn Sblendorio
Glenn Sblendorio Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Glenn Sblendorio owns 5 companies in total, including Amicus Therapeutics Inc (FOLD) , Intercept Pharmaceuticals Inc (ICPT) , and IVERIC bio Inc (ISEE) among others .
Click here to see the complete history of Glenn Sblendorio’s form 4 insider trades.
Insider Ownership Summary of Glenn Sblendorio
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2015-07-13 | director |
| ICPT | Intercept Pharmaceuticals Inc | 2020-05-28 | director |
| ISEE | IVERIC bio Inc | 2022-12-19 | director |
 | | 2015-09-03 | director & President & CFO |
| | 2023-09-13 | director |
Glenn Sblendorio Latest Holdings Summary
Glenn Sblendorio currently owns a total of 3 stocks. Among these stocks, Glenn Sblendorio owns 244,138 shares of IVERIC bio Inc (ISEE) as of December 19, 2022, with a value of $10 Million and a weighting of 53.19%. Glenn Sblendorio owns 99,805 shares of The Medicines Co (MDCO) as of September 3, 2015, with a value of $8 Million and a weighting of 46.21%. Glenn Sblendorio also owns 11,933 shares of Amicus Therapeutics Inc (FOLD) as of July 13, 2015, with a value of $110,142 and a weighting of 0.6%.
Latest Holdings of Glenn Sblendorio
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ISEE | IVERIC bio Inc | 2022-12-19 | 244,138 | 39.95 | 9,753,313 |
| MDCO | The Medicines Co | 2015-09-03 | 99,805 | 84.90 | 8,473,445 |
| FOLD | Amicus Therapeutics Inc | 2015-07-13 | 11,933 | 9.23 | 110,142 |
Holding Weightings of Glenn Sblendorio
Glenn Sblendorio Form 4 Trading Tracker
According to the SEC Form 4 filings, Glenn Sblendorio has made a total of 12 transactions in IVERIC bio Inc (ISEE) over the past 5 years, including 2 buys and 10 sells. The most-recent trade in IVERIC bio Inc is the sale of 19,457 shares on December 19, 2022, which brought Glenn Sblendorio around $418,520.
According to the SEC Form 4 filings, Glenn Sblendorio has made a total of 0 transactions in The Medicines Co (MDCO) over the past 5 years. The most-recent trade in The Medicines Co is the sale of 25,000 shares on September 3, 2015, which brought Glenn Sblendorio around $1 Million.
According to the SEC Form 4 filings, Glenn Sblendorio has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 10,000 shares on July 13, 2015, which brought Glenn Sblendorio around $150,000.
Insider Trading History of Glenn Sblendorio
- 1
Glenn Sblendorio Trading Performance
GuruFocus tracks the stock performance after each of Glenn Sblendorio's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glenn Sblendorio is 26.72%. GuruFocus also compares Glenn Sblendorio's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glenn Sblendorio within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Glenn Sblendorio's insider trading performs compared to the benchmark.
Performance of Glenn Sblendorio
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 39.89 | | | | | |
| Relative Return to S&P 500(%) | 37.9 | | | | | |
Glenn Sblendorio Ownership Network
Glenn Sblendorio Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Glenn Sblendorio is the director of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Glenn Sblendorio made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 634,200 shares made by John F Crowley , a net sale of 260,446 shares made by Bradley L Campbell , and a net sale of 51,919 shares made by David Michael Clark .
In summary, during the past 3 months, insiders sold 115,222 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 115,222 shares. During the past 18 months, 1,232,982 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,232,982 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Glenn Sblendorio Mailing Address
Above is the net worth, insider trading, and ownership report for Glenn Sblendorio. You might contact Glenn Sblendorio via mailing address: 3 Times Sqaure, 12th Floor, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
